GSK In Pact With India’s Dr Reddy’s; Digs Deeper Into Emerging Generic Drugs Market

MUMBAI - Expanding its reach further into emerging markets for generic drugs, GlaxoSmithKline said it has reached an agreement with Dr. Reddy's Labs to develop and market select products across an extensive number of countries, except India